VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 23 filers reported holding VERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,281,708 | +49618.1% | 453,689 | -76.0% | 0.00% | -50.0% |
| Q1 2023 | $14,646 | -31.7% | 1,887,351 | +70.2% | 0.01% | -33.3% |
| Q4 2022 | $21,452 | -99.7% | 1,108,649 | +179.3% | 0.01% | +140.0% |
| Q3 2022 | $8,459,000 | +125.0% | 396,928 | +43.7% | 0.01% | +150.0% |
| Q2 2022 | $3,760,000 | +19.9% | 276,243 | +106.9% | 0.00% | 0.0% |
| Q1 2022 | $3,136,000 | +190.6% | 133,500 | +63.9% | 0.00% | +100.0% |
| Q2 2021 | $1,079,000 | – | 81,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |